These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34927512)

  • 1. Clinical value of serum VEGF and sFlt-1 in pernicious placenta previa.
    Wang N; Shi D; Li N; Qi H
    Ann Med; 2021 Dec; 53(1):2041-2049. PubMed ID: 34927512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinguishing placenta accreta from placenta previa via maternal plasma levels of sFlt-1 and PLGF and the sFlt-1/PLGF ratio.
    Zhang F; Gu M; Chen P; Wan S; Zhou Q; Lu Y; Li L
    Placenta; 2022 Jun; 124():48-54. PubMed ID: 35635854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of vascular endothelial growth factor and placenta growth factor for placenta accreta spectrum.
    Faraji A; Akbarzadeh-Jahromi M; Bahrami S; Gharamani S; Raeisi Shahraki H; Kasraeian M; Vafaei H; Zare M; Asadi N
    J Obstet Gynaecol; 2022 Jul; 42(5):900-905. PubMed ID: 34558384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of ADAM17 and its clinical value for patients with pernicious placenta previa: A retrospective study of 148 PPP patients underwent cesarean section.
    Huang X; Wang X; Xiao X; Li J; Yuan H; Hou L
    Medicine (Baltimore); 2024 Feb; 103(6):e32848. PubMed ID: 38335437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placenta accreta/percreta/increta: a cause of elevated maternal serum alpha-fetoprotein.
    Zelop C; Nadel A; Frigoletto FD; Pauker S; MacMillan M; Benacerraf BR
    Obstet Gynecol; 1992 Oct; 80(4):693-4. PubMed ID: 1383899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accreta complicating complete placenta previa is characterized by reduced systemic levels of vascular endothelial growth factor and by epithelial-to-mesenchymal transition of the invasive trophoblast.
    Wehrum MJ; Buhimschi IA; Salafia C; Thung S; Bahtiyar MO; Werner EF; Campbell KH; Laky C; Sfakianaki AK; Zhao G; Funai EF; Buhimschi CS
    Am J Obstet Gynecol; 2011 May; 204(5):411.e1-411.e11. PubMed ID: 21316642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence factors and pregnancy outcomes for pernicious placenta previa with placenta accreta.
    Hou Y; Zhou X; Shi L; Peng J; Wang S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Sept 28; 45(9):1074-1081. PubMed ID: 33051421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of maternal serum VEGF, TNF-alpha, IL-4, and IL-10 levels in differentiating placenta accreta spectrum from isolated placenta previa.
    Farisoğullari N; Tanaçan A; Sakcak B; Denizli R; Baştemur AG; Başaran E; Kara Ö; Yazihan N; Şahin D
    Cytokine; 2024 Apr; 176():156513. PubMed ID: 38262117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and Ultrasound Predictors of Placenta Accreta in Pregnant Women with Antepartum Diagnosis of Placenta Previa: A Multicenter Study.
    De Vita D; Capobianco G; Gerosolima G; Sciorio C; Coppola E; Parazzini F; Silvestri M; Caruso AP; Morlando M; Petta R; Pascarella A; Dessole S; Viora E
    Gynecol Obstet Invest; 2019; 84(3):242-247. PubMed ID: 30448828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum angiogenic profile in abnormal placentation.
    Biberoglu E; Kirbas A; Daglar K; Biberoglu K; Timur H; Demirtas C; Karabulut E; Danisman N
    J Matern Fetal Neonatal Med; 2016 Oct; 29(19):3193-7. PubMed ID: 26863111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study.
    Fitzpatrick KE; Sellers S; Spark P; Kurinczuk JJ; Brocklehurst P; Knight M
    PLoS One; 2012; 7(12):e52893. PubMed ID: 23300807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble FMS-Like Tyrosine Kinase-1: Role in placenta accreta spectrum disorder.
    Lumbanraja S; Yaznil MR; Siahaan AM; Berry Eka Parda B
    F1000Res; 2021; 10():618. PubMed ID: 36127888
    [No Abstract]   [Full Text] [Related]  

  • 13. Does soluble fms-like tyrosine kinase-1 regulate placental invasion? Insight from the invasive placenta.
    McMahon K; Karumanchi SA; Stillman IE; Cummings P; Patton D; Easterling T
    Am J Obstet Gynecol; 2014 Jan; 210(1):68.e1-4. PubMed ID: 23994221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive placenta previa: Placental bulge with distorted uterine outline and uterine serosal hypervascularity at 1.5T MRI - useful features for differentiating placenta percreta from placenta accreta.
    Chen X; Shan R; Zhao L; Song Q; Zuo C; Zhang X; Wang S; Shi H; Gao F; Qian T; Wang G; Limperopoulos C
    Eur Radiol; 2018 Feb; 28(2):708-717. PubMed ID: 28770405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The correlation between serum levels and placental tissue expression of PLGF and sFLT-1 and the FIGO grading of the placenta accreta spectrum disorders.
    Alessandrini L; Aryananda R; Ariani G; Agustina B; Akbar MIA; Dachlan EG; Dekker G; Ernawati E
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2183744. PubMed ID: 36859823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Third-trimester ultrasound for antenatal diagnosis of placenta accreta spectrum in women with placenta previa: results from the ADoPAD study.
    Fratelli N; Prefumo F; Maggi C; Cavalli C; Sciarrone A; Garofalo A; Viora E; Vergani P; Ornaghi S; Betti M; Vaglio Tessitore I; Cavaliere AF; Buongiorno S; Vidiri A; Fabbri E; Ferrazzi E; Maggi V; Cetin I; Frusca T; Ghi T; Kaihura C; Di Pasquo E; Stampalija T; Belcaro C; Quadrifoglio M; Veneziano M; Mecacci F; Simeone S; Locatelli A; Consonni S; Chianchiano N; Labate F; Cromi A; Bertucci E; Facchinetti F; Fichera A; Granata D; D'Antonio F; Foti F; Avagliano L; Bulfamante GP; Calì G;
    Ultrasound Obstet Gynecol; 2022 Sep; 60(3):381-389. PubMed ID: 35247287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective study of placenta accreta, placenta increta and placenta percreta in Peripartum hysterectomy specimens.
    Heena AB; Kumari G
    Indian J Pathol Microbiol; 2020 Feb; 63(Supplement):S87-S90. PubMed ID: 32108636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of abnormally invasive placenta.
    Al-Khan A; Youssef YH; Feldman KM; Illsley NP; Remache Y; Alvarez-Perez J; Mannion C; Alvarez M; Zamudio S
    Placenta; 2020 Feb; 91():37-42. PubMed ID: 32174305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antenatal Sonographic Diagnosis and Clinical Significance of Placenta Previa Accreta after Cesarean Section.
    Liu ZZ; Wei Y; Wang RJ; Xu W; Shi ZM; Dai Q
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Oct; 39(5):693-698. PubMed ID: 29125114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Cripto-1 in the placenta and its role in placenta accreta and placenta previa.
    Jiang L; Wu X; Yan J; Chen R; Han Q; Zhang Q
    Ginekol Pol; 2019; 90(2):86-92. PubMed ID: 30860275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.